| P50 | author | Michael T Lotze | Q89121415 |
| | Daolin Tang | Q89676004 |
| | Herbert J. Zeh, III | Q92244196 |
| P2093 | author name string | Rui Kang | |
| | Herbert J. Zeh Iii | |
| P2860 | cites work | Guidelines for the use and interpretation of assays for monitoring autophagy | Q21996341 |
| | Endogenous HMGB1 regulates autophagy | Q24298865 |
| | LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing | Q24597817 |
| | Autophagy in the Pathogenesis of Disease | Q27860558 |
| | Induction of autophagy and inhibition of tumorigenesis by beclin 1 | Q28131718 |
| | High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal | Q28242907 |
| | HMGB1 and RAGE in inflammation and cancer | Q28274621 |
| | The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice | Q28510445 |
| | A Lymphocyte-stimulating Factor produced in vitro | Q29012645 |
| | Autophagy and the Integrated Stress Response | Q29547398 |
| | The role of autophagy during the early neonatal starvation period | Q29547489 |
| | Fibroblasts in cancer | Q29547753 |
| | The Beclin 1 network regulates autophagy and apoptosis | Q29616539 |
| | Self-eating and self-killing: crosstalk between autophagy and apoptosis | Q29617748 |
| | Eaten alive: a history of macroautophagy | Q29617841 |
| | Autophagy in health and disease: a double-edged sword | Q29618103 |
| | Stromal fibroblasts in cancer initiation and progression | Q29618873 |
| | High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993 | Q29619885 |
| | High-mobility group box 1 and cancer | Q33638306 |
| | Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell death | Q33999904 |
| | Pharmacologic administration of interleukin-2. | Q34092747 |
| | HMGB1 release and redox regulates autophagy and apoptosis in cancer cells | Q34154797 |
| | Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. | Q34198891 |
| | Death by design: apoptosis, necrosis and autophagy | Q34365753 |
| | The biology of interleukin-2. | Q34585827 |
| | Interleukin 2 in cancer therapy | Q34622499 |
| | IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice | Q35296962 |
| | High-Mobility Group Box 1 Is Essential for Mitochondrial Quality Control | Q35800479 |
| | Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase | Q36103541 |
| | Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression. | Q36157982 |
| | The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival | Q36157988 |
| | The role of autophagy in cancer development and response to therapy. | Q36251939 |
| | Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12 | Q36610857 |
| | Autophagy in cancer: good, bad, or both? | Q36612549 |
| | Fibroblast differentiation in wound healing and fibrosis | Q36729100 |
| | Fibroblasts as novel therapeutic targets in chronic inflammation | Q36983715 |
| | The double-edged sword of autophagy modulation in cancer | Q37331327 |
| | Autophagy inhibition in combination cancer treatment. | Q37639955 |
| | Eat-me: autophagy, phagocytosis, and reactive oxygen species signaling | Q38032609 |
| | HMGB1 promotes drug resistance in osteosarcoma | Q38330106 |
| | Tumor-Cell Death, Autophagy, and Immunity | Q39391354 |
| | Zinc signals promote IL-2-dependent proliferation of T cells | Q39732550 |
| | Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma | Q39887954 |
| | Cell type-specific roles of Jak3 in IL-2-induced proliferative signal transduction | Q40176773 |
| | Regulation of Akt-dependent cell survival by Syk and Rac. | Q40695243 |
| | Fibroblasts prevent apoptosis of IL-2-deprived T cells without inducing proliferation: a selective effect on Bcl-XL expression. | Q41153174 |
| | Characterization of the heterodimeric complex of human IL-2 receptor alpha.beta chains reconstituted in a mouse fibroblast cell line, L929. | Q41718812 |
| | Lung fibroblasts inhibit activation-induced death of T cells through PGE(2)-dependent mechanisms | Q43764567 |
| | Cytokine Gene Therapy with Interleukin-2-Transduced Fibroblasts: Effects of IL-2 Dose on Anti-Tumor Immunity | Q45866935 |
| | Hyaluronan synthesis is required for IL-2-mediated T cell proliferation | Q46868588 |
| | Expression of IL-2 receptor beta and gamma chains by human gingival fibroblasts and up-regulation of adhesion to neutrophils in response to IL-2. | Q54757626 |
| | Autophagy and cancer | Q56772657 |
| | Chapter 10 Monitoring Autophagy by Electron Microscopy in Mammalian Cells | Q57082870 |
| | Human fibroblasts express functional IL-2 receptors formed by the IL-2R alpha- and beta-chain subunits: association of IL-2 binding with secretion of the monocyte chemoattractant protein-1 | Q71384731 |
| | HMGB1: A novel Beclin 1-binding protein active in autophagy | Q85176562 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autophagy | Q288322 |
| P304 | page(s) | 556-565 | |
| P577 | publication date | 2012-11-27 | |
| P1433 | published in | Experimental Cell Research | Q1524289 |
| P1476 | title | Autophagy is required for IL-2-mediated fibroblast growth | |
| P478 | volume | 319 | |